Dallas, TX, United States of America

Emilian V Racila

This inventor holds 3 USPTO granted patents. Top assignees: Immunivest Corporation, Other. Active years: 2002-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emilian V Racila. Retrieved from https://idiyas.com/inventor/emilian-v-racila

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 631(Granted Patents)


Company Filing History:


Years Active: 2002-2008

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Emilian V Racila: Innovator in Cancer Cell Isolation

Introduction

Emilian V Racila is a notable inventor based in Dallas, TX (US), recognized for his contributions to the field of cancer research. He holds 3 patents that focus on innovative methods for isolating circulating cancer cells, which are crucial for early detection and treatment of cancer.

Latest Patents

One of his latest patents involves methods and reagents for the rapid and efficient isolation of circulating cancer cells. This highly sensitive assay combines immunomagnetic enrichment with multiparameter flow cytometric and immunocytochemical analysis. It is designed to detect, enumerate, and characterize carcinoma cells in the blood. Remarkably, the assay can detect one epithelial cell or less in 1 ml of blood, demonstrating greater sensitivity than conventional PCR or immunohistochemistry by 1-2 orders of magnitude. Additionally, this assay facilitates the biological characterization and staging of carcinoma cells.

Career Highlights

Throughout his career, Emilian has worked with various organizations, including Immunivest Corporation. His work has significantly advanced the methodologies used in cancer diagnostics and treatment.

Collaborations

Emilian has collaborated with esteemed professionals in his field, including Leon W M M Terstappen and Galla Chandra Rao. These collaborations have further enriched his research and innovations.

Conclusion

Emilian V Racila's work in the isolation of circulating cancer cells represents a significant advancement in cancer diagnostics. His innovative approaches continue to impact the field positively, paving the way for improved patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…